Replies to post #344995 on Avid Bioservices Inc (CDMO)

[eb0783]

OT: He is for real but living on hopeum. I’ve countered him on a couple of things in the past, but I don’t want to bust his bubble. I feel for him….. he lost his wife a while back after caring for her in her last years and he lives alone on a lake, with limited income. He lives and breathes HGEN and Lenz and does very good dd on their situation. He has been in the stock for years and knows management pretty well. He is a straight shooter and, you might have noticed, he is more considerate with some people than I would be. 😊 I emailed with him in the spring when I was trying to get compassionate use of Lenzilumab to go with the CAR-T I was given for my relapsed DLB Lymphoma. I emailed with the HGEN CEO, also, and he was ready/eager to talk to my Oncologist. However my Oncologist didn’t want to jump through the hoops at his hospital and he put me on another trial instead, which was not as good as Lenz. That was in March-April and I am in complete remission now, so it worked out.

[north40000]

WH, while you’re looking for good, but risky, investments, take a long look at AMRN and the clinical trial P. I. Dr. C. Carlsson at U. Wisconsin recently released, anticipating (IMO) a potential accelerated FDA approval of Vascepa in Alzheimer’s Disease, dementia, PTSD, depression, etc. The Phase 3 BRAVE trial of Vascepa completed 9/29/2023, after running for greater than 2-6 years, and her hypothesis + AIMS 1-3 are now under data analysis. I have been prescribed Vascepa (4 capsules/day) since 4/2013. The plan for BRAVE trial now is to run a Phase 4 confirmatory trial of 18 months in more patients to show FDA that the data ensuing from AIMS 1-3 do reveal Vascepa effectiveness in treating biomarkers. My mother died in 2000, not Knowing my brother or me.

[dorf1]

Hey Wildhorses, I am also wondering about "that guy" on HGEN. Sounds legit in some ways but then again...?